Within-class differences of the sulfonylureas should be accounted for.

Suppr

超能文献

作者信息

Schrijnders Dennis, Kleefstra Nanne, Landman Gijs W D

机构信息

Diabetes Centre, Isala Clinics, Dokter Spanjaardweg 11, 8025 BT, Zwolle, the Netherlands,

出版信息

Diabetologia. 2015 Jun;58(6):1374-5. doi: 10.1007/s00125-015-3556-1. Epub 2015 Mar 24.

DOI:10.1007/s00125-015-3556-1

PMID:25800142

Abstract

摘要

相似文献

Within-class differences of the sulfonylureas should be accounted for.

Diabetologia. 2015 Jun;58(6):1374-5. doi: 10.1007/s00125-015-3556-1. Epub 2015 Mar 24.

Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].

Diabetologia. 2015 Jun;58(6):1376-7. doi: 10.1007/s00125-015-3574-z. Epub 2015 Mar 26.

[Clinical efficacy of glimepiride].格列美脲的临床疗效

Nihon Rinsho. 1997 Nov;55 Suppl:152-7.

[Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].

Ter Arkh. 1988;60(12):91-6.

The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide.奥曲肽对一名正在服用格列本脲的2型糖尿病患者血糖和胰岛素水平的影响。

Diabetes Metab. 1999 Sep;25(4):347-9.

Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.

Diabetes Technol Ther. 2000 Autumn;2(3):479-80. doi: 10.1089/15209150050194350.

Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.与格列本脲相比，瑞格列奈治疗在葡萄糖刺激后可使血糖水平和β细胞分泌更快下降。

Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):466-71. doi: 10.1002/dmrr.474.

[From insulin secretion to insulin therapy].[从胰岛素分泌到胰岛素治疗]

Presse Med. 1998;27(24):1240-6.

The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.格列本脲治疗对II型糖尿病患者胰岛素分泌及胰岛素与红细胞结合的影响。

Braz J Med Biol Res. 1988;21(1):35-42.

Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.格列本脲可增强β细胞对葡萄糖的反应性，但不能纠正非胰岛素依赖型糖尿病患者胰岛素分泌的异常模式。

J Clin Endocrinol Metab. 1989 Sep;69(3):571-6. doi: 10.1210/jcem-69-3-571.

引用本文的文献

Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment.发展中国家2型糖尿病的管理：在最佳血糖控制及治疗效果与治疗的可负担性和可及性之间取得平衡

Diabetes Ther. 2020 Jan;11(1):15-35. doi: 10.1007/s13300-019-00733-9. Epub 2019 Nov 26.

Modern Sulfonylureas Strike Back - Exploring the Freedom of Flexibility.现代磺脲类药物卷土重来——探寻灵活性的自由。

Eur Endocrinol. 2018 Sep;14(2):20-22. doi: 10.17925/EE.2018.14.2.20. Epub 2018 Sep 10.

本文引用的文献

The effect of glibenclamide on insulin secretion at normal glucose concentrations.格列本脲在正常葡萄糖浓度下对胰岛素分泌的影响。

Diabetologia. 2015 Jan;58(1):43-9. doi: 10.1007/s00125-014-3399-1. Epub 2014 Oct 9.

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials.格列齐特治疗2型糖尿病的安全性和有效性：随机试验的系统评价和荟萃分析

PLoS One. 2014 Feb 12;9(2):e82880. doi: 10.1371/journal.pone.0082880. eCollection 2014.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.KDIGO 临床实践指南：糖尿病与慢性肾脏病（2012 年更新版）

Am J Kidney Dis. 2012 Nov;60(5):850-86. doi: 10.1053/j.ajkd.2012.07.005.

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.与二甲双胍相比，不同胰岛素促分泌剂在有或无既往心肌梗死的 2 型糖尿病患者中的死亡率和心血管风险：一项全国性研究。

Eur Heart J. 2011 Aug;32(15):1900-8. doi: 10.1093/eurheartj/ehr077. Epub 2011 Apr 6.

A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study.一项比较维格列汀和格列齐特与二甲双胍联合治疗单用二甲双胍血糖控制不佳的 2 型糖尿病患者的疗效和安全性的 52 周、随机研究。

Diabet Med. 2010 Mar;27(3):318-26. doi: 10.1111/j.1464-5491.2010.02938.x.

Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes.在初治 2 型糖尿病患者中单用两年后，DPP-4 抑制剂维格列汀与磺酰脲类格列齐特的疗效和安全性比较。

Horm Metab Res. 2009 Dec;41(12):905-9. doi: 10.1055/s-0029-1234042. Epub 2009 Aug 24.

A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.低血糖与心血管事件的系统评价和荟萃分析：格列本脲与其他促泌剂及胰岛素的比较

Diabetes Care. 2007 Feb;30(2):389-94. doi: 10.2337/dc06-1789.

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients.GUIDE研究：2型糖尿病患者中每日一次格列齐特缓释片与格列美脲的双盲比较。

Eur J Clin Invest. 2004 Aug;34(8):535-42. doi: 10.1111/j.1365-2362.2004.01381.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验